← Clinical Pharmacology Advances and Applications
Papers in Clinical Pharmacology Advances and Applications
Page 3 · newest first
- Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatmentClinical Pharmacology Advances and Applications · 2019
- Assessing the effect of omega-3 fatty acid combined with vitamin D3 versus vitamin D3 alone on estradiol levels: a randomized, placebo-controlled trial in females with vitamin D deficiencyClinical Pharmacology Advances and Applications · 2019
- Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapyClinical Pharmacology Advances and Applications · 2019
- Method development and validation of ursodiol and its major metabolites in human plasma by HPLC-tandem mass spectrometryClinical Pharmacology Advances and Applications · 2019
- Treatment of acne with a combination of propolis, tea tree oil, and Aloe vera compared to erythromycin cream: two double-blind investigationsClinical Pharmacology Advances and Applications · 2018
- Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjectsClinical Pharmacology Advances and Applications · 2018
- 12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitusClinical Pharmacology Advances and Applications · 2018
- The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cellsClinical Pharmacology Advances and Applications · 2018
- Mechanisms and the clinical relevance of complex drug–drug interactionsClinical Pharmacology Advances and Applications · 2018
- Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxinClinical Pharmacology Advances and Applications · 2018
- A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspensionClinical Pharmacology Advances and Applications · 2018
- Distribution of pomalidomide into semen of healthy male subjects after multiple dosesClinical Pharmacology Advances and Applications · 2018
- Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indicationsClinical Pharmacology Advances and Applications · 2018
- Safinamide: an add-on treatment for managing Parkinson’s diseaseClinical Pharmacology Advances and Applications · 2018
- Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapyClinical Pharmacology Advances and Applications · 2018
- A review of the pharmacology and clinical efficacy of brivaracetamClinical Pharmacology Advances and Applications · 2018
- CRTH2 antagonists in asthma: current perspectivesClinical Pharmacology Advances and Applications · 2017
- Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcomaClinical Pharmacology Advances and Applications · 2017
- Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal functionClinical Pharmacology Advances and Applications · 2017
- Role of afatinib in the treatment of advanced lung squamous cell carcinomaClinical Pharmacology Advances and Applications · 2017
- Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseasesClinical Pharmacology Advances and Applications · 2017
- Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacinClinical Pharmacology Advances and Applications · 2017
- NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatmentClinical Pharmacology Advances and Applications · 2017
- Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective studyClinical Pharmacology Advances and Applications · 2017
- Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label studyClinical Pharmacology Advances and Applications · 2017
- The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjectsClinical Pharmacology Advances and Applications · 2017
- Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigationsClinical Pharmacology Advances and Applications · 2017
- Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerationsClinical Pharmacology Advances and Applications · 2017
- Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteersClinical Pharmacology Advances and Applications · 2017
- A Phase I study evaluating the effect of age and weight on the pharmacokinetics of an injectable formulation of diclofenac solubilized with hydroxypropyl-β-cyclodextrinClinical Pharmacology Advances and Applications · 2016
- Skin models for the testing of transdermal drugsClinical Pharmacology Advances and Applications · 2016
- Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteersClinical Pharmacology Advances and Applications · 2016
- LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectivesClinical Pharmacology Advances and Applications · 2016
- Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjectsClinical Pharmacology Advances and Applications · 2016
- Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesClinical Pharmacology Advances and Applications · 2016
- The effect of weight, body mass index, age, sex , and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysisClinical Pharmacology Advances and Applications · 2016
- Systematic review and network meta-analysis of stroke-prevention treatments in patients with atrial fibrillationClinical Pharmacology Advances and Applications · 2016
- The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapiesClinical Pharmacology Advances and Applications · 2016
- Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary interventionClinical Pharmacology Advances and Applications · 2016
- Clinical use and applications of histone deacetylase inhibitors in multiple myelomaClinical Pharmacology Advances and Applications · 2016
- Differential pharmacology and clinical utility of empagliflozin in type 2 diabetesClinical Pharmacology Advances and Applications · 2016
- Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infectionsClinical Pharmacology Advances and Applications · 2016
- Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infectionsClinical Pharmacology Advances and Applications · 2015
- Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffnessClinical Pharmacology Advances and Applications · 2015
- Pharmacokinetics and skin-tissue penetration of daptomycin in ratsClinical Pharmacology Advances and Applications · 2015
- Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalinClinical Pharmacology Advances and Applications · 2015
- Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathwaysClinical Pharmacology Advances and Applications · 2015
- Carbon monoxide: a critical quantitative analysis and review of the extent and limitations of its second messenger functionClinical Pharmacology Advances and Applications · 2015
- Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockersClinical Pharmacology Advances and Applications · 2015
- Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteersClinical Pharmacology Advances and Applications · 2015